Marie E McKeon
Overview
Explore the profile of Marie E McKeon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paranjpe M, Belich J, Mann P, McKeon M, Elbekai R, Brown C, et al.
Toxicol Pathol
. 2018 Nov;
47(1):18-25.
PMID: 30407148
This article presents the historical control data of spontaneous tumors in Tg.rasH2 published in 2013 (2004-2012) and compares and contrasts it to more recent data collected from 2013 to 2018,...
2.
Paranjpe M, Belich J, Richardson D, Vidmar T, Mann P, McKeon M, et al.
Int J Toxicol
. 2016 Jul;
36(1):29-34.
PMID: 27440821
Tg.rasH2 mice are predisposed to hemangiosarcomas. Following the spleen, the uterus is the second most commonly affected organ in the female mice. Female mice are also predisposed to spontaneous vascular...
3.
Fielden M, Dean Jr C, Black K, Sawant S, Subramanian R, Tomlinson J, et al.
Int J Toxicol
. 2016 Mar;
35(3):294-308.
PMID: 26941242
Etelcalcetide is a novel d-amino acid peptide that functions as an allosteric activator of the calcium-sensing receptor and is being developed as an intravenous calcimimetic for the treatment of secondary...
4.
Paranjpe M, Belich J, McKeon M, Elbekai R, Mann P, Hard G, et al.
Toxicol Pathol
. 2016 Feb;
44(5):633-5.
PMID: 26883151
We report renal tubular adenomas and a carcinoma in 26-week Tg.rasH2 mouse carcinogenicity studies, which have not been reported to date either at our facility or in other published data....